In advanced BC, the expression of CCN5 protein correlated significantly (P < 0.05) with PR, HER-2 (Fig. 3), Ki-67, P53, tumour diameter, histological grade, lymph node metastasis, pathological molecular subtype, and clinical staging. Here, TP53 is linked to breast cancer.